Biomarkers in Barrett's esophagus
- 1 April 2003
- journal article
- review article
- Published by Elsevier in Gastrointestinal Endoscopy Clinics of North America
- Vol. 13 (2) , 369-397
- https://doi.org/10.1016/s1052-5157(03)00006-0
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- p53 Mutations in Barrett's esophagus predict poor response to photodynamic therapyGastroenterology, 2001
- Interobserver variation in barrett's (BE) related high-grade dysplasia (HGD) and superficial adenocarcinoma: Can it be improved using uniform pathologic criteria?Gastroenterology, 2000
- Significance of multiple mutations in cancerCarcinogenesis: Integrative Cancer Research, 2000
- Cancer Cell CyclesScience, 1996
- p53: puzzle and paradigm.Genes & Development, 1996
- Mutations of p53 in barrett's esophagus and barrett's cancer: A prospective study of ninety-eight casesThe Journal of Thoracic and Cardiovascular Surgery, 1996
- The value of p53 and Ki67 as markers for tumour progression in the Barrett's dysplasia-carcinoma sequenceSurgical Oncology, 1995
- Dysplasia and aneuploidy as markers of malignant degeneration in Barrett's oesophagus. The Rotterdam Oesophageal Tumour Study Group.Gut, 1994
- p53 Mutations in Human CancersScience, 1991
- The Clonal Evolution of Tumor Cell PopulationsScience, 1976